Brian Joseph Cahill - 19 Dec 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Issuer symbol
EGRX
Transactions as of
19 Dec 2022
Net transactions value
-$13,844
Form type
4
Filing time
21 Dec 2022, 15:17:28 UTC
Previous filing
02 Mar 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $13,844 -461 -1.4% $30.03 32,206 19 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The disposition reported on this Form 4 represents shares withheld by the company to satisfy tax withholding obligations in connection with the settlement of restricted stock units.